Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

ClinicalTrials.gov ID: NCT06736041

Public ClinicalTrials.gov record NCT06736041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 4:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) compared with 20-valent pneumococcal vaccine (Prevnar 20, licensed pneumococcal conjugate vaccine) when they are administered with routine pediatric vaccines in infants aged from approximately 2 months (42 to 89 days). The study duration per participant will be up to approximately 19 months. The study vaccines (either PCV21 or 20-valent pneumococcal vaccines) will be administered at approximately 2, 4, 6 and 12 to 15 months of age. Routine pediatric vaccines will be given at the same timepoints. There will be 6 study visits: -Visit (V)01, V02 separated from V01 by 60 days, V03 separated from V02 by 60 days, V04 separated from V03 by 30 days, V05 at 12 months of age until 15 months of age, V06 separated from V05 by 30 days.

Study identification

NCT ID
NCT06736041
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
1,714 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
42 Days to 89 Days
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2024 (Actual)
Primary completion
May 17, 2027 (Estimated)
Completion
May 17, 2027 (Estimated)
Last update posted
Apr 22, 2026

2024 – 2027

United States locations

U.S. sites
66
U.S. states
22
U.S. cities
51
Facility City State ZIP Site status
Sun City Clinical Research- Site Number : 8400247 Glendale Arizona 85304 —
Eclipse Clinical Research- Site Number : 8400029 Tucson Arizona 85745 —
Northwest Arkansas Pediatric Clinic- Site Number : 8400030 Fayetteville Arkansas 72703 —
Southland Clinical Research Center- Site Number : 8400243 Fountain Valley California 92708 —
Century Research Institute- Site Number : 8400065 Huntington Park California 90255 —
Matrix Clinical Research - Huntington Park- Site Number : 8400012 Huntington Park California 90255 —
Matrix Clinical Research - Los Angeles- Site Number : 8400013 Los Angeles California 90057 —
University of California Los Angeles Medical Center- Site Number : 8400238 Los Angeles California 90095 —
Pasadena Clinical Trials - Pasadena - North Madison Avenue- Site Number : 8400259 Pasadena California 91101 —
FOMAT Medical Research - Pediatric, Infant & Adolescence Medicine- Site Number : 8400063 Ventura California 93003 —
Velocity Clinical Research - Washington DC- Site Number : 8400049 Washington D.C. District of Columbia 20016 —
PAS Research- Site Number : 8400123 Clearwater Florida 33756 —
Prohealth Research Center- Site Number : 8400159 Doral Florida 33166 —
NurtureGen Research- Site Number : 8400205 Homestead Florida 33030 —
EMDA Clinical Research- Site Number : 8400237 Miami Florida 33126 —
Dade Research Center- Site Number : 8400007 Miami Florida 33135 —
Acevedo Clinical Research Associates- Site Number : 8400089 Miami Florida 33142 —
Miami Clinical Research Tower- Site Number : 8400189 Miami Florida 33155 —
Vasconcello-Cohen MD Research, LLC- Site Number : 8400248 Miami Florida 33183 —
Bio-Medical Research- Site Number : 8400147 Miami Florida 33184 —
High Quality Research- Site Number : 8400245 Miami Florida 33184 —
Riveldi Biomedical Research and Associates - Miami Lakes- Site Number : 8400032 Miami Lakes Florida 33014 —
BioResearch Partner (BRP) - Premium Healthcare Medical Center - Miami Lakes- Site Number : 8400203 Miami Lakes Florida 33016 —
Optimal Research Sites- Site Number : 8400232 Orange City Florida 32763 —
SEC Clinical Research - Pensacola- Site Number : 8400003 Pensacola Florida 32501 —
National Clinical Trials - Tampa- Site Number : 8400229 Tampa Florida 33612 —
PAS Research - Tampa- Site Number : 8400002 Tampa Florida 33613 —
Medical Research Partners - Ammon- Site Number : 8400239 Ammon Idaho 83406 —
Bingham Memorial Hospital - Blackfoot- Site Number : 8400084 Blackfoot Idaho 83221 —
Leavitt Women's Healthcare- Site Number : 8400085 Idaho Falls Idaho 83404 —
Snake River Research- Site Number : 8400060 Idaho Falls Idaho 83404 —
Clinical Research Prime Rexburg- Site Number : 8400250 Rexburg Idaho 83440 —
Alliance for Multispeciality Research - El Dorado- Site Number : 8400010 El Dorado Kansas 67042 —
Hutchinson Clinic- Site Number : 8400061 Hutchinson Kansas 67502 —
Cotton O'Neil Pediatrics- Site Number : 8400009 Topeka Kansas 66604 —
KUR Research at Columbia MD - 6220 Old Dobbin Lane- Site Number : 8400242 Columbia Maryland 21045 —
Michigan Institute of Research- Site Number : 8400207 Allen Park Michigan 48101 —
University of Missouri Hospital- Site Number : 8400244 Columbia Missouri 65212 —
Vector Clinical Trials- Site Number : 8400249 Las Vegas Nevada 89128 —
Hawthorne- Bienstar Lindenwold- Site Number : 8400256 Lindenwold New Jersey 08021 —
University of New Mexico Health Sciences Center- Site Number : 8400240 Albuquerque New Mexico 87131-0001 —
Hawthorne Health - Staten Island- Site Number : 8400254 Staten Island New York 10309 —
Prime Global Research- Site Number : 8400246 The Bronx New York 10456 —
Monroe Biomedical Research - Monroe- Site Number : 8400225 Monroe North Carolina 28112 —
Dayton Clinical Research- Site Number : 8400087 Dayton Ohio 45409 —
Oklahoma State University Center for Health Sciences- Site Number : 8400121 Tulsa Oklahoma 74107 —
Allegheny Health Network - Health and Wellness Pavilion- Site Number : 8400111 Erie Pennsylvania 16506 —
Tribe Clinical Research - Greenville - Verdae Boulevard- Site Number : 8400005 Greenville South Carolina 29607 —
Coastal Carolina Research Center - North Charleston- Site Number : 8400064 North Charleston South Carolina 29405 —
Inquest Clinical Research - Baytown - West Baker Road- Site Number : 8400112 Baytown Texas 77521 —
South Texas Clinical Research- Site Number : 8400025 Corpus Christi Texas 78413 —
FamilyHealthWatch - KeyPoint Clinical Research- Site Number : 8400173 Dallas Texas 75237 —
Helios Clinical Research - Fort Worth - 8th Avenue- Site Number : 8400072 Fort Worth Texas 76104 —
Ventavia Research Group - Houston - North Loop West- Site Number : 8400093 Houston Texas 77008 —
Gonzalez Family & Occupational Medicine- Site Number : 8400035 Houston Texas 77029 —
Private Practice - Dr. Chinyere N. Awa- Site Number : 8400252 Houston Texas 77057 —
La Providence Pediatrics & Family Clinics- Site Number : 8400026 Houston Texas 77071 —
Houston Clinical Research Associates- Site Number : 8400018 Houston Texas 77090 —
Biopharma Informatic - Katy - Katy Freeway- Site Number : 8400258 Katy Texas 77450 —
Maximos Ob/Gyn- Site Number : 8400056 League City Texas 77573 —
Pediatric Center - Richmond- Site Number : 8400068 Richmond Texas 77469 —
LinQ Research, LLC - Rosharon- Site Number : 8400257 Rosharon Texas 77583 —
Tanner Clinic - Layton Antelope A- Site Number : 8400241 Layton Utah 84041 —
Wasatch Pedicatrics- Site Number : 8400153 Murray Utah 84107 —
Rio Clinical Trials - Canyon View- Site Number : 8400222 Ogden Utah 84404 —
Clinical Research Partners - Richmond - Forest Avenue- Site Number : 8400236 Richmond Virginia 23220 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06736041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06736041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →